Ridgetech Inc. current report, Q4 FY2022

Filing Overview

This Form 6-K was filed on December 6, 2022, by China Jo-Jo Drugstores, Inc., a Cayman Islands company and foreign private issuer. The filing reports the results of the company’s annual meeting held December 2, 2022, for the fiscal year ended March 31, 2022. The request metadata identifies the company as Ridgetech Inc.; however, the filing text identifies China Jo-Jo Drugstores, Inc.

Business and Reporting Context

The filing concerns shareholder voting and corporate governance matters. It does not provide operating or financial results for the reporting period.

Financial and Liquidity Metrics

  • Revenue, profit, cash flow, margins, debt, cash balances, liquidity, and other financial metrics: the filing text does not provide clear values.

Shareholder Vote Results

  • Board elections: Lei Liu, Li Qi, Caroline Wang, Jiangliang He, Genghua Gu, and Pingfan Wu were elected to serve until the next annual meeting and until their successors are elected and qualified.
  • Independent auditor: Shareholders ratified YCM CPA, Inc. as the independent registered public accounting firm for the fiscal year ending March 31, 2023, with 6,127,783 votes for, 291 against, and no abstentions.
  • Equity incentive plan: Shareholders approved the Second Amended and Restated 2010 Equity Incentive Plan, with 6,063,421 votes for, 64,446 against, and 93 abstentions.

Material Changes, Outlook, and Risks

The filing does not report material changes in financial performance, management guidance, business outlook, contingencies, or unusual items. It also does not disclose new risks or debt and liquidity developments.

Key Facts to Verify

  • Confirm the issuer identity, because the filing names China Jo-Jo Drugstores, Inc., while the request metadata names Ridgetech Inc.
  • Review the company’s annual report for the fiscal year ended March 31, 2022 for financial results and liquidity information not included in this Form 6-K.
  • Assess the terms, potential dilution, and accounting impact of the approved amended equity incentive plan.
  • Confirm the auditor’s appointment and any subsequent auditor changes in later filings.